Mostrando ítems 52-54 de 6664

    • Neoplasm related mortality risk in Systemic Sclerosis: a nationwide study 

      Martínez-Urbistondo, María; González-Guzmán, Antonio; Fernández-Guitián, Román; Blanco-Valencia, Xiomara Patricia; Esteban-Sampedro, Jorge; Martín-Portugués, Mario; Durán-del Campo, Pedro; Tutor, Pablo; Mellor-Pita, Susana; Ortega-de la Puente, Alfonso; de la Cruz-Echeandía, Marina; Moreno-Torres, Víctor (BMC Rheumatology, 2025)
      Background The higher mortality rates in patients with Systemic sclerosis (SSc) are related to SSc activity, cardiovascular disease, and neoplasms, among other factors. Our objective was to assess the impact of solid ...
    • Castleman's disease: one disease, multiple etiologies 

      Esteban-Sampedro, Jorge; Martín-Portugués, Mario; Durán-del Campo, Pedro; Fernández-Güitián, Román; Ruiz-Becerra, Jaime E.; Moreno-Torres, Víctor (AIDS Review, 2024)
      Castleman disease (CD) comprises a heterogeneous group of rare lymphoproliferative disorders characterized by similar morphological features in nodal biopsies. Since Benjamin Castleman's initial description in 1956, our ...
    • Higher Mortality Risk From Ovarian Carcinomas, Small Bowel Neoplasms, and B-Cell and Mucosa-Associated Lymphoid Tissue Lymphomas in Sjögren Syndrome Patients 

      Vázquez-Comendador, José Manuel; Mateos Seirul-lo, María; Martínez-Urbistondo, María; Miguel-Ontañón, Nuria; González-Guzmán, Antonio; Fernández-Guitián, Román; Castejón, Raquel; Durán-del Campo, Pedro; Tutor, Pablo; Mellor-Pita, Susana; Moreno-Torres, Víctor (Journal of Clinical Rheumatology, 2025)
      Objective To evaluate the impact of the different types of neoplasms and lineages on Sjögren syndrome (SjS) patient mortality. Methods Medical records review study based on the Spanish Hospital Discharge Database ...